Shen C, Xie H, Jiang X, Wang L
J Pharmacokinet Pharmacodyn. 2025; 52(1):13.
PMID: 39821812
DOI: 10.1007/s10928-025-09961-y.
Hoefman S, van Steeg T, Ottevaere I, Baumeister J, Rossenu S
J Pharmacokinet Pharmacodyn. 2024; 52(1):2.
PMID: 39636455
PMC: 11621151.
DOI: 10.1007/s10928-024-09952-5.
Yu H, Chen Y, Qi Y, Yang H, Cao G, Yang W
CNS Neurosci Ther. 2024; 30(11):e70126.
PMID: 39592888
PMC: 11598743.
DOI: 10.1111/cns.70126.
Zasedateleva T, Schaller S, de Lange E, de Witte W
CPT Pharmacometrics Syst Pharmacol. 2024; 13(12):2068-2086.
PMID: 39530200
PMC: 11646940.
DOI: 10.1002/psp4.13262.
Xu M, Sun D, An G
AAPS J. 2024; 26(6):112.
PMID: 39467882
DOI: 10.1208/s12248-024-00979-7.
Randomized, double-blind, phase 1a single-ascending dose and food effect studies assessing safety and pharmacokinetics of EC5026 in healthy volunteers.
Schmidt W, Cortes-Puch I, McReynolds C, Croston G, Hwang S, Yang J
Clin Transl Sci. 2024; 17(9):e70033.
PMID: 39300734
PMC: 11413051.
DOI: 10.1111/cts.70033.
General quasi-equilibrium multivalent binding model to study diverse and complex drug-receptor interactions of biologics.
Ng C, Bauer R
J Pharmacokinet Pharmacodyn. 2024; 51(6):841-857.
PMID: 39153154
DOI: 10.1007/s10928-024-09936-5.
Formulation and Validation of an Extended Sigmoid Emax Model in Pharmacodynamics.
Byun J
Pharm Res. 2024; 41(9):1787-1795.
PMID: 39143408
DOI: 10.1007/s11095-024-03752-9.
Dupilumab: Mechanism of action, clinical, and translational science.
McCann M, Kosloski M, Xu C, Davis J, Kamal M
Clin Transl Sci. 2024; 17(8):e13899.
PMID: 39080841
PMC: 11288895.
DOI: 10.1111/cts.13899.
Recombinant Adeno-Associated Virus Vectors for Gene Therapy of the Central Nervous System: Delivery Routes and Clinical Aspects.
Slyk Z, Stachowiak N, Malecki M
Biomedicines. 2024; 12(7).
PMID: 39062095
PMC: 11274884.
DOI: 10.3390/biomedicines12071523.
Validity conditions of approximations for a target-mediated drug disposition model: A novel first-order approximation and its comparison to other approximations.
Byun J, Jeon H, Yun H, Kim J
PLoS Comput Biol. 2024; 20(4):e1012066.
PMID: 38656966
PMC: 11090311.
DOI: 10.1371/journal.pcbi.1012066.
Emerging therapeutic drug monitoring technologies: considerations and opportunities in precision medicine.
Liang W, Beaulieu-Jones B, Smalley S, Snyder M, Goetz L, Schork N
Front Pharmacol. 2024; 15:1348112.
PMID: 38545548
PMC: 10965556.
DOI: 10.3389/fphar.2024.1348112.
A physiologically-based pharmacokinetic/pharmacodynamic modeling approach for drug-drug-gene interaction evaluation of S-warfarin with fluconazole.
Geng K, Shen C, Wang X, Wang X, Shao W, Wang W
CPT Pharmacometrics Syst Pharmacol. 2024; 13(5):853-869.
PMID: 38487942
PMC: 11098157.
DOI: 10.1002/psp4.13123.
A mechanism-based pathway toward administering highly active N-phage cocktails.
Smith N, Nguyen T, Chin W, Sanborn J, de Souza H, Ho B
Front Microbiol. 2023; 14:1292618.
PMID: 38045026
PMC: 10690594.
DOI: 10.3389/fmicb.2023.1292618.
Celastrol ameliorates energy metabolism dysfunction of hypertensive rats by dilating vessels to improve hemodynamics.
Zou G, Yu R, Zhao D, Duan Z, Guo S, Wang T
J Nat Med. 2023; 78(1):191-207.
PMID: 38032498
DOI: 10.1007/s11418-023-01759-x.
Low-dimensional neural ODEs and their application in pharmacokinetics.
Bram D, Nahum U, Schropp J, Pfister M, Koch G
J Pharmacokinet Pharmacodyn. 2023; 51(2):123-140.
PMID: 37837491
PMC: 10982100.
DOI: 10.1007/s10928-023-09886-4.
Clinical and research updates on the VISTA immune checkpoint: immuno-oncology themes and highlights.
Noelle R, Lines J, Lewis L, Martell R, Guillaudeux T, Lee S
Front Oncol. 2023; 13:1225081.
PMID: 37795437
PMC: 10547146.
DOI: 10.3389/fonc.2023.1225081.
Alternate Antimicrobial Therapies and Their Companion Tests.
Kalpana S, Lin W, Wang Y, Fu Y, Wang H
Diagnostics (Basel). 2023; 13(15).
PMID: 37568853
PMC: 10417861.
DOI: 10.3390/diagnostics13152490.
Population Target-Mediated Pharmacokinetic/Pharmacodynamic Modeling to Evaluate SPI-62 Exposure and Hepatic 11β-Hydroxysteroid Dehydrogenase Type 1 (HSD-1) Inhibition in Healthy Adults.
Wu N, Katz D, An G
Clin Pharmacokinet. 2023; 62(9):1275-1288.
PMID: 37452998
PMC: 10449972.
DOI: 10.1007/s40262-023-01278-8.
A Pharmacometrics Model to Characterize a New Type of Target-Mediated Drug Disposition (TMDD) - Nonlinear Pharmacokinetics of Small-Molecule PF-07059013 Mediated By Its High-capacity Pharmacological Target Hemoglobin With Positive Cooperative Binding.
Xu M, An G
AAPS J. 2023; 25(3):41.
PMID: 37055588
DOI: 10.1208/s12248-023-00808-3.
